These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 25322760

  • 21. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 22. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC, Paraskeva C.
    Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 25. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB.
    J Exp Ther Oncol; 2005 Nov 01; 5(1):69-78. PubMed ID: 16416603
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 01; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 28. Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway.
    Bao MH, Zhang YW, Zhou HH.
    J Ethnopharmacol; 2013 Mar 27; 146(2):543-51. PubMed ID: 23357312
    [Abstract] [Full Text] [Related]

  • 29. Aspisol inhibits tumor growth and induces apoptosis in breast cancer.
    Zhu XG, Tao L, Mei ZR, Wu HP, Jiang ZW.
    Exp Oncol; 2008 Dec 27; 30(4):289-94. PubMed ID: 19112426
    [Abstract] [Full Text] [Related]

  • 30. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production.
    Sun GP, Wang H, Xu SP, Shen YX, Wu Q, Chen ZD, Wei W.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):246-52. PubMed ID: 18329639
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chemopreventive effects of Khaya senegalensis bark extract on human colorectal cancer.
    Androulakis XM, Muga SJ, Chen F, Koita Y, Toure B, Wargovich MJ.
    Anticancer Res; 2006 Apr 28; 26(3B):2397-405. PubMed ID: 16821623
    [Abstract] [Full Text] [Related]

  • 33. Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells.
    Zeng L, Zhen Y, Chen Y, Zou L, Zhang Y, Hu F, Feng J, Shen J, Wei B.
    Int J Oncol; 2014 Nov 28; 45(5):1929-36. PubMed ID: 25174821
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P.
    Breast Cancer Res; 2005 Nov 28; 7(4):R422-35. PubMed ID: 15987447
    [Abstract] [Full Text] [Related]

  • 35. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
    Zhang L, Tao L, Shi T, Zhang F, Sheng X, Cao Y, Zheng S, Wang A, Qian W, Jiang L, Lu Y.
    IUBMB Life; 2015 Oct 28; 67(10):778-88. PubMed ID: 26452780
    [Abstract] [Full Text] [Related]

  • 36. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
    Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M.
    Cancer Res; 2006 Mar 01; 66(5):2683-90. PubMed ID: 16510588
    [Abstract] [Full Text] [Related]

  • 37. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
    Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK.
    Cancer Res; 2006 Oct 01; 66(19):9705-13. PubMed ID: 17018629
    [Abstract] [Full Text] [Related]

  • 38. The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes expression.
    Atari-Hajipirloo S, Nikanfar S, Heydari A, Noori F, Kheradmand F.
    Cell Mol Biol (Noisy-le-grand); 2016 Feb 29; 62(2):68-74. PubMed ID: 26950454
    [Abstract] [Full Text] [Related]

  • 39. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO, Beales IL.
    Regul Pept; 2006 Mar 15; 134(1):1-8. PubMed ID: 16169610
    [Abstract] [Full Text] [Related]

  • 40. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
    Venkatesan P, Bhutia SK, Singh AK, Das SK, Dash R, Chaudhury K, Sarkar D, Fisher PB, Mandal M.
    Life Sci; 2012 Oct 22; 91(15-16):789-99. PubMed ID: 22922496
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.